Over 3,000 Nigerians, including 800 children, are caught in a life-threatening crisis as the supply of Multi-Drug Therapy (MDT), a critical treatment for leprosy, remains stalled for more than 10 months.
This alarming reality was revealed during a press briefing by the Integration Dignity and Economic Advancement (IDEA-Nigeria), the National Association of Persons Affected by Leprosy in Abuja, the nations capital.
The group described the delay as a catastrophic failure fueled by bureaucratic bottlenecks, threatening the health, dignity, and lives of thousands of Nigerians.
“These delays are not just numbers; they represent lives, children, mothers, fathers who are being left to suffer preventable disabilities and worsening stigma,” lamented Mr. Peter Iorkighir Terver, President of IDEA-Nigeria.
The President of IDEA-Nigeria, Mr. Peter Iorkighir Terver said the supply of MDT, donated under WHO’s global program, has been delayed due to regulatory requirements by the National Agency for Food and Drug Administration and Control (NAFDAC). A demand for a Certificate of Pharmaceutical Product (CoPP) for Rifampicin, despite its global acceptance, has stalled the process.
“Adding to the urgency, key permits and inspection reports are set to expire within weeks. If unresolved, the delay could extend well into late 2025, further compounding the suffering of those affected.
“For leprosy patients, the consequences of untreated cases go beyond physical health, many face permanent disabilities, social isolation, and discrimination. Moreover, untreated cases increase disease transmission, posing a broader public health risk
“This is not just about medicine; it’s about human rights. These delays perpetuate the marginalization and suffering of persons affected by leprosy,” he added.
Mr. Terve called on President Bola Ahmed Tinubu to intervene and ensure the immediate release of MDT.
IDEAE-Nigeria called for: A waiver from NAFDAC to expedite drug delivery, Streamlined processes for donated medicines to prevent future delays, Prompt distribution of MDT to all affected individuals before the end of 2024.
“We Cannot Afford More Delays.” The association emphasized that the time for action is now, urging government officials, regulatory bodies, and international partners to prioritize the crisis.
“We are at a critical juncture. This is not the time for bureaucracy but for bold and compassionate leadership,” Terver appealed.
As the December 31 permit expiration looms, the fate of over 3,000 Nigerians lies in the hands of decision-makers. The question remains: will they act swiftly to save lives, or will this crisis deepen further? For those awaiting MDT, every day is a fight against time and hope.
Comments are closed.